SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-030437
Filing Date
2024-03-12
Accepted
2024-03-12 21:36:30
Documents
1
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 18171
  Complete submission text file 0000950170-24-030437.txt   20554
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Issuer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address KRAUSENSTRASSE 9-10 BERLIN 2M 10117
Business Address KRAUSENSTRASSE 9-10 BERLIN 2M 10117 4917632963813
ATAI Life Sciences AG (Reporting) CIK: 0001776242 (see all company filings)

State of Incorp.: 2M | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-31187 | Film No.: 24744397

Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Reporting) CIK: 0001840904 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-31187 | Film No.: 24744398
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)